Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc. (MDMA.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdma.cn · pe ratio · data through Aug 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Pharmala Biotech Holdings Inc. (MDMA.CN) measures how much investors pay for each dollar of the company's trailing earnings. MDMA.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.14 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-08-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pharmala Biotech Holdings Inc.You MDMA.CN | $16M | N/A | — | -$0.01 |
 BetterLife Pharma Inc. BETR.CN | $11M | N/A | — | -$0.01 |
 Britannia Life Sciences Inc. BLAB.CN | $14M | 1.65x | — | $0.05 |
 Comprehensive Healthcare Systems, Inc. CHS.V | $10M | N/A | — | -$0.15 |
 Glow Lifetech Corp. GLOW.CN | $10M | N/A | — | -$0.00 |
 Hemostemix Inc. HEM.V | $11M | N/A | — | -$0.03 |
 Medicure Inc. MPH.V | $11M | N/A | — | -$0.68 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-08-31Latest FY2025 | — | $-0.02 | — | |
2024-08-31 FY2024 | — | $-0.01 | — | |
2023-08-31 FY2023 | — | $-0.01 | — | |
2022-08-31 FY2022 | — | $-0.01 | — | |
2021-08-31 FY2021 | — | $-0.03 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pharmala Biotech Holdings Inc. (MDMA.CN) measures how much investors pay for each dollar of the company's trailing earnings. MDMA.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.14 by its TTM earnings per share of -$0.01.
Frequently asked questions
MDMA.CN pe ratio · 6 questionsMDMA.CN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.14 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via MDMA.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pharmala Biotech Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08